HQL abrdn Life Sciences Investors (HQL) Insider Trading, Ownership & Congress Trades
Other · CIK 0000884121
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
55
13F, latest reported quarter
What the filings say about HQL
Insiders, 180 days
+$10.5K net bought
1 buyer
abrdn Life Sciences Investors insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, abrdn Life Sciences Investors insiders bought a net $10.5K of stock across 82 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 100.0% of the 527 shares held after it.
- No other insider bought within 30 days.
- 55 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Mahai Chris LaVictoire bought about $10.5K of HQL on Jul 16, 2026; 55 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 100.0% of the 7,923 shares held after it.
- No other insider bought within 30 days.
- 55 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Pittard Christian bought about $133.7K of HQL on Dec 16, 2025, the largest insider purchase at the company since 2024; 55 funds added in the latest 13F quarter.Context
- 32 earlier Form 4 trades (code P or S) here by this insider (13 buys, 19 sales), the last on Sep 19, 2025.
- +13.4% median (+15.4% mean) 90-day return after 13 previous buys.
- The trade is 1.5% of the 2,837,633 shares held after it.
- 1 other insider sold within 30 days.
- 55 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Saba Capital Management, L.P. sold about $588.5K of HQL on Sep 22, 2025; 1 other insider sold within 30 days and 55 funds added in the latest 13F quarter.Context
- 31 earlier Form 4 trades (code P or S) here by this insider (13 buys, 18 sales), the last on Sep 18, 2025.
- +13.4% median (+15.4% mean) 90-day return after 13 previous buys.
- The trade is 0.2% of the 2,879,256 shares held after it.
- 1 other insider sold within 30 days.
- 55 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Saba Capital Management, L.P. sold about $98.5K of HQL on Sep 19, 2025; 1 other insider sold within 30 days and 55 funds added in the latest 13F quarter.Context
- 30 earlier Form 4 trades (code P or S) here by this insider (13 buys, 17 sales), the last on Sep 17, 2025.
- +13.4% median (+15.4% mean) 90-day return after 13 previous buys.
- The trade is 1.4% of the 2,886,245 shares held after it.
- 1 other insider sold within 30 days.
- 55 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Saba Capital Management, L.P. sold about $565.7K of HQL on Sep 18, 2025; 1 other insider sold within 30 days and 55 funds added in the latest 13F quarter.82 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$10.5K over 180 days
below 62% of all 58 companies we track
Congress
no House purchase disclosed in the last 12 months
Funds
55 funds bought in last quarter
more than 71% of all 58 companies we track
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
1.0 days to cover · settled 2026-09-30
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch HQL
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+19.0%12M
Insider buy
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns HQL: institutional holders (13F)
13F holdings, latest reported quarter
1,771,848 sh
$35.5M
689,134 sh
$13.8M
514,161 sh
$10.3M
$9.1M
443,041 sh
$8.9M
Congress trades in HQL
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
HQL planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
HQL mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Modern Capital Tactical Income Fund
$2.7M position · as of 2026-06-30
3.9%
Amplify CEF High Income ETF
$16.7M position · as of 2026-06-30
2.3%
First Trust Income Opportunities ETF
$1.0M position · as of 2026-05-31
1.3%
Saba Closed-End Funds ETF
$821.3K position · as of 2026-05-31
0.2%
Multi-Hedge Strategies Fund
$5.4K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $10.5K bought by insiders over 180 days, 55 funds added last quarter. Each figure is a federal filing, dated the day it went public.
HQL Stock Sonar score 2/7 axes
Find similar shapesCompare2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HQL filings, in plain words
Are abrdn Life Sciences Investors insiders buying or selling HQL?
In the 180 days to 2026-10-27, abrdn Life Sciences Investors insiders were net buyers, a net $10.5K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-27, abrdn Life Sciences Investors insiders were net buyers of HQL, a net $10.5K across purchases and sales reported on Form 4 by 1 buyer. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
